20/20 Biolabs, Inc. (AIDX) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$0.27

From 52W high−98.91%

Volume399878.00

Market cap$3.32M

P/E (TTM)—

P/S (TTM)1.6x

Div yield—

Key dataOct 19, 2026

Open

$0.27

From 52W high

−98.91%

Volume

399878.00

Market cap

$3.32M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.2x

P/E (TTM)

—

RSI (14)

22.5

MomentumView details →

1D Return

−0.12%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−0.2x

EV/Sales

0.4x

P/S (TTM)

1.6x

P/B (TTM)

1.1x

ProfitabilityView details →

Gross Margin

31.52%

Net Margin

−285.00%

EBITDA Margin

−235.10%

ROE (TTM)

−184.04%

ROA (TTM)

−94.96%

Asset Turnover

0.34x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

−43.03%

EPS CAGR 3Y

+48.28%

EBITDA YoY

—

MomentumView details →

1D Return

−0.12%

YTD Return

—

1Y Return

—

RSI (14)

22.5

vs 50D SMA

−45.06%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

0.18x

Current Ratio

1.99x

Quick Ratio

1.95x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.26

EPS Surprise

−116.67%

Beats (12Q)

0/12

Next Q EPS Est

−$0.07

Avg Surprise (4Q)

−116.67%

Rev Surprise

14.87%

Financials snapshotView financials →

Revenue (TTM)

2.04M

Net Income (TTM)

−5.81M

Op. CF (TTM)

−2.79M

Latest newsMore news →

Nasdaq notified 20/20 Biolabs, Inc. on September 3, 2026 that it failed to comply with the $2.5 million stockholders' equity requirement under Listing Rule 5550(b)(1), giving the company 45 calendar days to submit a compliance plan.39d ago

BioLabs announced Carmen Schicklberger as site director for BioLabs Rochester, MN, and Geof Hannigan as Mayo Clinic's director of startup engagement.47d ago

Similar companies

Adagio Medical Holdings, Inc.ADGM Bluejay Diagnostics, Inc.BJDX IceCure Medical LtdICCM Inspira Technologies Oxy B.H.N. Ltd.IINNW Vivos Therapeutics, Inc.VVOS Pheton Holdings Ltd Class A Ordinary SharesPTHL Find similar companies →

Latest newsMore news →

Nasdaq notified 20/20 Biolabs, Inc. on September 3, 2026 that it failed to comply with the $2.5 million stockholders' equity requirement under Listing Rule 5550(b)(1), giving the company 45 calendar days to submit a compliance plan.39d ago BioLabs announced Carmen Schicklberger as site director for BioLabs Rochester, MN, and Geof Hannigan as Mayo Clinic's director of startup engagement.47d ago BioLabs Rochester, MN announced it will open its 17,000-square-foot shared laboratory and office facility in September 2026, with recruitment underway for resident companies.47d ago